Cardiac Disorder Articles & Analysis
8 news found
About Atrial Fibrillation AF is one of the most common sustained cardiac rhythm disorders (arrhythmias). It results from rapid, disorganized electrical signals in the upper chambers (atria) of the heart, causing them to quiver and contract quickly and irregularly. ...
ByBayer AG
About atrial fibrillation (AF) and chronic kidney disease (CKD) AF is the most common sustained cardiac rhythm disorder. In AF, the upper chambers of the heart (atria) contract irregularly. ...
ByBayer AG
About Atrial Fibrillation AF is the most common sustained cardiac rhythm disorder. In AF, the upper chambers (atria) of the heart contract irregularly.5 As a result, the atria do not empty completely, and blood does not flow properly, potentially allowing blood clots to form. ...
ByBayer AG
The full-scale mitochondrial studies can greatly simplify pharmaceutical and biotech partners’ preclinical research targeted to mitochondria-related disorders such as cardiac disease, neurodegeneration, diabetes, and other human diseases. ...
The Pfizer focus on rare disease builds on more than two decades of experience, a dedicated research unit focusing on rare disease, and a global portfolio of multiple medicines within a number of disease areas of focus, including rare hematologic, neurologic, cardiac and inherited metabolic disorders. Pfizer Rare Disease combines pioneering science and deep ...
The patent portfolio covers the use of both the non-invasive external TNS (eTNS®) and the minimally-invasive subcutaneous TNS (sTNS) embodiments to treat a wide spectrum of indications, including neurological, neuropsychiatric, cardiac, and autoimmune disorders, along with enabling features enhancing product safety, ease of use, adaptive feedback control, and ...
Bardy, M.D. Dr. Bardy has been a cardiac electrophysiologist since 1983 with research interests in cardiac defibrillator technology, cardiac arrest, ablation, heart failure and atrial fibrillation from both a public health and a technological perspective. He has been a researcher and clinician in the field of sudden death and disabling ...
Especially for degenerative diseases where cell loss and low self-repair potential occur, such as cardiac muscle loss or degenerative neurological disorders, regenerative cell therapy offers unprecedented potential to have a significant benefit for patients. BlueRock Therapeutics’ portfolio of cell therapies is currently focused on neurology, cardiology ...